Faculty, Graduate Program
Studies over the past several years have demonstrated that pathways regulating processes such as cell fate decisions and organ size control, during development, also play pivotal roles during tumorigenesis. While many of the individual signal transduction pathways have been outlined, a major ongoing challenge has been to integrate these findings into a comprehensive map of cellular signaling networks. Our lab is studying the signal transduction pathways regulated by small GTP-binding proteins from the Ras and Rac families and how these pathways crosstalk with pathways controlling cell fate and organ size control, such as the Notch, Wnt and Hpo/YAP pathways.
B.Sc., Life Sciences, Ben-Gurion University, Beer-Sheva, Israel, 1993
Ph.D., Molecular Biology, Weizmann Institute of Science, Rehovot, Israel, 1999
Ph.D. research- Weizmann Institute of Science, 1993-1999
Postdoctoral fellowship - Massachusetts Institute of Technology, 1999-2004
1999-2001 "Human Frontier Science Program" Award
2001-2003 NF Foundation "Young Investigator Award"
2003-2004 R.L. Kirchstein National Research Service Award
2010-2012 American Cancer Society Research Scholar Award.
2014 Scripps Florida Outstanding Mentor Award
Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L.C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L., Stanger, B.Z. and Kissil, J.L. “Angiomotin-p130 is required for Yap-mediated hepatic epithelial cell expansion and tumorigenesis”. Science Signal. 2013 Sep 3;6(291):ra77
Zhou, C., Troutman, S., Maksimoska, J., Liu, Q., Campbell, D., Marmorstein, R. and Kissil, J.L. “FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of NF2-associated schwannomas“.J. Biol. Chem. 288(40):29105-14, 2013.
Licciulli, S., Avila, J.L., Hanlon, L., Troutman, S., Cesaroni, M., Keith, B., Simon, M.C., Pure, E., Radtke, F., Capobianco, A.J. and Kissil, J.L. “Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cells survival via p53”. Cancer Res. 73(19):5974-84, 2013
Chun, Z., Licciulli, S., Avila, J.L., Cho, M., Troutman, S., Jiang, P., Vachani, A., Albelda, S.M. and Kissil, J.L. “Rac1b, a splice form of Rac1, promotes K-ras-induced lung tumorigenesis”. Oncogene 32(7):903-9, 2012.
Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila J, Christian N, Persson NL, Speicher DW, Shimono A, Marmorstein R, Holmgren L and Kissil J. "A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin’s Regulation of Mitogenic Signaling and Tumor Suppressive Functions" Cancer Cell. 2011 April 19:527-540.
Yi, C. and Kissil, J.L. “Merlin in organ size control and tumorigenesis: Hippo versus EGFR?”. Genes & Dev. 24:1673-80, 2010
Hanlon, L., Avila, J.L., Demarest, R.M., Troutman, S., Allen, M., Ratti, F., Rustgi, A.K., Stanger, B.Z., Radtke, F., Adsay, V., Long, F., Capobianco, A.J. and Kissil, J.L. “Notch1 functions as a tumor suppressor in K-ras-induced pancreatic ductal adenocarcinoma”. Cancer Res. 70: 4280-6, 2010
Santos, A.M., Jung, J., Aziz, N., Kissil, J.L.# and Puré E.# (#Equal contribution). “Targeting the Stroma Cell Protease Fibroblast Activation Protein Inhibits Tumor Growth”. J. Clin. Invest. 119:3613-25, 2009
Yi, C., Wilker, E.W., Yaffe, M.B., Stemmer-Rachamimov, A. and Kissil, J.L. “Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Res. 68:7932-7, 2008